These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 839097)

  • 1. Advanced prostatic cancer revisited--35 years later.
    Jacobo E; Culp DA
    J Iowa Med Soc; 1977 Feb; 67(2):52-5. PubMed ID: 839097
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of a new imidazole derivative in advanced prostatic cancer. A preliminary report.
    Mahler C; Denis L; De Coster R
    Prog Clin Biol Res; 1989; 303():205-9. PubMed ID: 2476819
    [No Abstract]   [Full Text] [Related]  

  • 3. Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate).
    Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Aro J; Ervasti J; Hansson E; Hurme K; Juusela H; Mäkinen J
    Ann Chir Gynaecol; 1985; 74(6):277-83. PubMed ID: 4096480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic carcinoma. Incidence and significance of stage I - preclinical carcinoma].
    Schmassmann A; Mihatsch MJ
    Urologe A; 1983 Sep; 22 Suppl():388-92. PubMed ID: 6685389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    Ott C; Fulton MK
    J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated impact of the prostate cancer prevention trial on population mortality.
    Zeliadt SB; Etzioni R; Kristal AR
    Cancer; 2005 Oct; 104(7):1556-7; author reply 1557. PubMed ID: 16015625
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of advanced prostatic cancer.
    Murphy GP
    Rev Surg; 1977; 34(2):75-87. PubMed ID: 854703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 9. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States.
    Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
    Anticancer Res; 2006; 26(1B):575-80. PubMed ID: 16739323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on etoposide therapy of relapsing prostatic cancer patients].
    Moriyama M; Murai T; Kondoh I
    Hinyokika Kiyo; 1990 Jul; 36(7):777-81. PubMed ID: 2239575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminoglutethimide in the treatment of advanced prostatic cancer.
    Murray R; Pitt P
    Prog Clin Biol Res; 1987; 243A():275-82. PubMed ID: 3658999
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide in advanced prostatic cancer relapsing under hormonal treatment.
    Verhelst J; De Longueville M; Ongena P; Denis L; Mahler C
    Acta Urol Belg; 1994 Apr; 62(1):83-8. PubMed ID: 7515212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PSA and hormone-refractory period in prostatic cancer].
    Ojea Calvo A; Verez M; Alonso A; Rodríguez B; Domínguez F; Benavente J; Barros JM; Nogueira March JL
    Actas Urol Esp; 1996 Feb; 20(2):168-71. PubMed ID: 8677815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H; Greenstein A; Kaver I; Braf Z
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histological study of prostatic cancer. Prognostic and therapeutic value].
    Bouffioux C
    J Urol Nephrol (Paris); 1974 Dec; 80(12 pt 2):531-40. PubMed ID: 4469333
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy for advanced prostate cancer: 25 years later.
    Logothetis CJ; Millikan R
    J Clin Oncol; 2008 May; 26(15):2423-4. PubMed ID: 18487561
    [No Abstract]   [Full Text] [Related]  

  • 18. Melphalan in advanced prostatic cancer: a pilot study.
    Houghton AL; Robinson MR; Smith PH
    Cancer Treat Rep; 1977 Aug; 61(5):923-4. PubMed ID: 890698
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of efficacy and tolerability of Nilutamide and Buserelin in the treatment of advanced prostate cancer.
    Migliari R; Scarpa RM; Campus G; De Lisa A; Zucca I; D'Atri M; Serra A; Usai E
    Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):147-53. PubMed ID: 1830407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomorphosis of prostatic cancer after regional endolymphatic polychemotherapy].
    Danil'chenko SA; Shlopov VG; Serniak PS; Geev IuV
    Vrach Delo; 1986 Jun; (6):77-80. PubMed ID: 3750969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.